Of the 40 recertification units (RUs) required for a CRNI® to recertify, at least 30 RUs must be obtained by attending any INS Meeting (live or online). Up to 10 RUs may be earned from the non INS Meeting category. The learning assets in this section have all been approved for RUs. Virtual Conferences meet the INS Meeting (internal) criteria. Webinars meet the non INS Meeting (external) criteria. All webinars are free to INS members.

CRNI® Recertification Approved

Search by Category
Search by Format
Sort By
Search by Favorites
Search by Keyword

  • INS 2025 Virtual Conference
    Contains 21 Product(s)

    The INS 2025 Virtual Conference offers an excellent alternative for those unable to attend the in-person event. Participants can access 20 curated sessions virtually and on-demand, providing CRNI®s the opportunity to earn up to 40 recertification units (RUs). The virtual conference will feature sessions from the Vascular Access Device (VAD) Track, focusing on the critical role of vascular access devices in infusion therapy, the Alternative Care Setting Track, highlighting patient care beyond acute care environments, and the new Global Initiatives Track, focusing on infusion therapy initiatives in countries from all over the world.

    The INS 2025 Virtual Conference offers an excellent alternative for those unable to attend the in-person event. Participants can access 20 curated sessions virtually and on-demand, providing CRNI®s the opportunity to earn up to 40 recertification units (RUs).

    The virtual conference will feature sessions from the Vascular Access Device (VAD) Track, focusing on the critical role of vascular access devices in infusion therapy, the Alternative Care Setting Track, highlighting patient care beyond acute care environments, and the new Global Initiatives Track, focusing on infusion therapy initiatives in countries from all over the world.

  • A Study Comparing Heparin Versus Saline Lock
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 04/08/2025 at 1:00 PM (EDT)

    Patients receiving bone marrow transplants commonly present with a plan of care that requires a peripherally inserted central catheter (PICC) placement. A gap in best practices guidance for this specific patient type was identified. When organizational standard of care policies vary based on the latest evidence, nurse-led research examines population-specific comparison data for organizational policy changes. In this session, we will explore a case study and outline the steps of how the research process enabled nurses in an inpatient bone marrow transplant unit to change PICC line locking practice guidance for oncology patients.

    Patients receiving bone marrow transplants commonly present with a plan of care that requires a peripherally inserted central catheter (PICC) placement. A gap in best practices guidance for this specific patient type was identified.

    When organizational standard of care policies vary based on the latest evidence, nurse-led research examines population-specific comparison data for organizational policy changes. In this session, we will explore a case study and outline the steps of how the research process enabled nurses in an inpatient bone marrow transplant unit to change PICC line locking practice guidance for oncology patients.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Critique the steps in the research process
    • Using the internal organizational research processes, analyze a nurse-led research study
    • Discuss the strategies to engage key stakeholders in implementing an organizational practice change

    Linda Denke, PhD, RN, CCRC

    Linda Denke, PhD, RN, CCRC, is a senior nurse scientist at UT Southwestern Medical Center, Dallas, Texas, and a globally respected figure in academic medical center nursing research. Her international recognition is evidenced by her invitations to present at over 34 conferences, nationally and internationally, where she has influenced thousands. Dr Denke’s portfolio includes over 40 academic medical center research studies focusing on mental health and integrating physical and mental health into holistic care, engaging interdisciplinary teams across acute and ambulatory settings.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: April 8, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • An Introduction to REBYOTA® (fecal microbiota, live - jslm), the Patient Experience & Administration Training
    Contains 2 Component(s)

    This session will provide an in-depth exploration of the role the microbiome plays in overall health and its impact on the pathogenesis and recurrence of Clostridioides difficile infection (rCDI). Attendees will gain a comprehensive understanding of the mechanisms behind rCDI, including the significant burden it places on patients both during and after acute infection. We will delve into the microbial composition, potency, and standardized manufacturing process of REBYOTA® (fecal microbiota, live-jslm), an FDA-approved therapeutic option for rCDI. Participants will have the opportunity to review key efficacy and safety data from clinical trials, providing evidence of REBYOTA® in clinical settings. Through patient case studies, we will also discuss the practical application of REBYOTA® in real-world clinical practice, offering valuable insights into its role in managing and preventing rCDI recurrence. This session is ideal for health care professionals looking to deepen their knowledge of microbiome-related diseases and explore innovative treatments for recurrent CDI.

    image

    This session will provide an in-depth exploration of the role the microbiome plays in overall health and its impact on the pathogenesis and recurrence of Clostridioides difficile infection (rCDI). Attendees will gain a comprehensive understanding of the mechanisms behind rCDI, including the significant burden it places on patients both during and after acute infection.

    We will delve into the microbial composition, potency, and standardized manufacturing process of REBYOTA® (fecal microbiota, live-jslm), an FDA-approved therapeutic option for rCDI. Participants will have the opportunity to review key efficacy and safety data from clinical trials, providing evidence of REBYOTA® in clinical settings.
    Through patient case studies, we will also discuss the practical application of REBYOTA® in real-world clinical practice, offering valuable insights into its role in managing and preventing rCDI recurrence. This session is ideal for health care professionals looking to deepen their knowledge of microbiome-related diseases and explore innovative treatments for recurrent CDI.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Understand the role of the microbiome in overall health, pathogenesis of Clostridioides difficile infection (CDI), and the burden of rCDI
    • Learn about REBYOTA®, review efficacy and safety data, and discuss patient case studies
    • Review step-by-step how to administer REBYOTA® 

    This webinar does not offer any continuing education credits or recertification units. 

    Candace L. Cotto, RN

    Candace Cotto, RN, has been a nurse for 45 years. She started her career as a critical care nurse, then switched focus to research at the YALE Cancer Center. She's been a research nurse in Gastroenterology for 10 years, with a focus on Clostridioides difficile infection (CDI) clinical trials and has worked on REBYOTA® trials since 2017; the most recent trial being the PUNCH CD3-OLS trial, which led to US Food and Drug Administration (FDA) approval in November 2022. She has performed over 120 REBYOTA procedures. Ms Cotto has spoken in numerous forums on recurrent CDI (rCDI) and was published in Gastroenterology Nurse, Sep-Oct 2024 (Prevention of Recurrent Clostridioides difficile Infection: What Gastroenterology Nurses Need to Know). She has been on the Speaker Board for REBYOTA with Ferring Pharmaceuticals since it received FDA approval.

  • Administration and Safety of Intravenous Iron
    Contains 3 Component(s), Includes Credits Recorded On: 02/11/2025

    Intravenous (IV) iron is a crucial treatment option for iron deficiency (ID) and iron deficiency anemia (IDA), especially in cases where oral iron supplements are insufficient, poorly tolerated, or ineffective. It is important for clinicians who are infusing IV iron to understand how to administer IV iron, assess and intervene if hypersensitivity reactions occur, and treat post-infusion hypophosphatemia. In this session, we will provide guidance on the administration of and classification of IV iron formulations, classification of, and management of infusion reactions and treatment-emergent hypophosphatemia.

    image

    Intravenous (IV) iron is a crucial treatment option for iron deficiency (ID) and iron deficiency anemia (IDA), especially in cases where oral iron supplements are insufficient, poorly tolerated, or ineffective. It is important for clinicians who are infusing IV iron to understand how to administer IV iron, assess and intervene if hypersensitivity reactions occur, and treat post-infusion hypophosphatemia. In this session, we will provide guidance on the administration of and classification of IV iron formulations, classification of, and management of infusion reactions and treatment-emergent hypophosphatemia.

    Learning Objectives: At the conclusion of this session, learners will be able to:
    • Know the intravenous iron formulations and their administration
    • Describe and recognize complement-mediated hypersensitivity reaction (CARPA) 
    • Discuss the management of hypersensitivity reactions to intravenous iron
    • Recognize formulations that lead to treatment-emergent hypophosphatemia and the populations most affected. 

    Layla Van Doren, MD, MBA

    Dr. Layla Van Doren, MD, MBA is an Assistant Professor of Medicine at Yale School of Medicine, where she specializes in classical hematology with an expertise in the diagnosis and management of iron- related disorders, including iron deficiency and anemia.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: February 11, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Integrating Patient- and Family-Centered Care in Vascular Access Management
    Contains 3 Component(s), Includes Credits Recorded On: 01/15/2025

    This session explores the principles of Patient- and Family-Centered Care (PFCC) through the compelling story of an individual living with Short Bowel Syndrome (SBS) since birth, requiring long-term vascular access for 35 years. Audience members will gain insight on strategies to enhance patient and family centered care for individuals living with chronic vascular access needs in their patient settings. This session will highlight patient experiences, health care delivery challenges, and barriers to accessing appropriate and timely care. There will be a focus on resources, language to use, and actions to take to promote collaborative and compassionate delivery of care.

    This session explores the principles of Patient- and Family-Centered Care (PFCC) through the compelling story of an individual living with Short Bowel Syndrome (SBS) since birth, requiring long-term vascular access for 35 years. Audience members will gain insight on strategies to enhance patient and family centered care for individuals living with chronic vascular access needs in their patient settings. This session will highlight patient experiences, health care delivery challenges, and barriers to accessing appropriate and timely care. There will be a focus on resources, language to use, and actions to take to promote collaborative and compassionate delivery of care.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Learn an example of the rare gastrointestinal (GI) chronic disease journey
    • Explain Patient- and Family-Centered Care (PFCC)
    • Describe the challenges and gaps in requiring long-term vascular access
    • Discuss strategies to implement a patient and family-centered approach in current care routine
    • Illustrate the mechanisms behind successful partnerships between patient/family and clinical care providers 

    Swapna Kakani, MPH

    Swapna Kakani, MPH, is an advocate, speaker, consultant, and researcher in rare and chronic disease health care delivery and patient experience. Through her platform, Swapna Speaks, Swapna has spoken across the world to various companies and associations and has given a TEDx talk. Swapna also does health care advocacy, research, and policy work for the intestinal failure, vascular access, and broader rare disease communities in her home state of Alabama and nationally. In 2017, she founded Alabama Rare, an organization advancing health care policy and education for Alabama’s rare disease community. In 2021, she, alongside parent researchers/advocates, co-founded the gutsy perspective, a research initiative driven by members of the short bowel syndrome community to ensure the patient and family narrative is represented in research and patient-centered outcomes. Swapna was born with short bowel syndrome and has lived with a combination of total parenteral nutrition (TPN), IV fluids, tube feeding, and an ostomy for 35 years. She received a small intestine transplant 10 years ago. Swapna resides in Huntsville, AL, and received her Master's degree in Public Health at the University of Alabama at Birmingham.

    Swapna Kakani, MPH (she/her/hers)
    Advocate - Speaker - Consultant - Researcher
    E: info@swapnakakani.com
    W Consultant: www.SwapnaKakani.com
    W Researcher: community-driven research on life with SBS | the gutsy perspective
    W Policy Action: www.alabamarare.org

    imageimageimageimage

    image

    the gutsy perspective
    thegutsyperspective.org 

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 15, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Exploration of the Current State of PIVC Placement and Complications: Clinical Implications
    Contains 3 Component(s), Includes Credits Recorded On: 11/20/2024

    This session will provide an overview of findings gleaned from a point prevalence study on PIVC placement and complications. Details regarding the study process and associated findings will be provided. Lessons learned and education and practice implications will also be explored.

    This session will provide an overview of findings gleaned from a point prevalence study on PIVC placement and complications. Details regarding the study process and associated findings will be provided. Lessons learned and education and practice implications will also be explored.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    ● Describe the process for a point prevalence study
    ● Discuss common findings gleaned from the point prevalence study
    ● Identify recommended practices to improve PIVC documentation and complication recognition

    Judy Smith, MSN, RN, CRNI®

    Judy Smith, MSN, RN, CRNI®, serves as Director of Vascular Access and Wound Care for Ascension Seton in Austin, Texas. She completed her BSN at the University of Texas at Austin in 1995 and her MSN in Healthcare Systems Management at Loyola University New Orleans in 2010. She has worked in the Vascular Access specialty for 21 years and published 2 research studies on disinfection of needleless connectors and 1 point prevalence study related to PIVC complications and documentation. She has presented at many Vascular Access and Infusion Therapy conferences in the United States and New Zealand. Judy enjoys reading and spending time with her family, especially her 2 grandsons.

    Vallire Hooper, PhD, RN, CPAN, FASPAN, FAAN

    Vallire Hooper, PhD, RN, CPAN, FASPAN, FAAN, is a Senior Nurse Scientist with Ascension. She has been a nurse for over 35 years, with a primary focus in perianesthesia nursing, working as a staff nurse, Clinical Nurse Specialist, and lastly, as a Clinical Nurse Scientist for the last 14 years. Dr Hooper obtained her PhD in Nursing from the Medical College of Georgia in 2009, with a research focus on factors influencing the multidisciplinary adoption of evidence-based clinical practice guidelines. She is a Fellow in the American Society of PeriAnesthesia Nurses as well as the American Academy of Nursing. Dr Hooper’s primary research interests include clinically focused patient outcomes research and factors influencing nursing care delivery.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: November 20, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Vapocoolants and Needle Procedures – Just the Facts
    Contains 3 Component(s), Includes Credits Recorded On: 10/16/2024

    Pain management is a priority for health care workers. In recent years, the potential of unwanted side effects from systemic pain medications has been highlighted. Health care practitioners are exploring and using topical anesthetics as an alternative for pain relief in minor procedures. Vapocoolants are topical anesthetics that contain no medication and provide transient anesthesia through evaporation-induced skin cooling, which reduces pain. This comprehensive overview will explore the broad vapocoolant category, describe clinical study results when using skin refrigerants for needle procedures, and review the 2024 INS Standards of Practice regarding vapocoolants.

    image

    Pain management is a priority for health care workers. In recent years, the potential of unwanted side effects from systemic pain medications has been highlighted. Health care practitioners are exploring and using topical anesthetics as an alternative for pain relief in minor procedures. Vapocoolants are topical anesthetics that contain no medication and provide transient anesthesia through evaporation-induced skin cooling, which reduces pain. This comprehensive overview will explore the broad vapocoolant category, describe clinical study results when using skin refrigerants for needle procedures, and review the 2024 INS Standards of Practice regarding vapocoolants. 

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Define vapocoolants and their mechanism of action
    • Describe clinical studies concerning vapocoolant use in needle procedures
    • Discuss the 2024 INS Standards of Practice concerning Vapocoolants

    Nancy Moureau, PhD, RN, CRNI®, CPUI™, VA-BC

    Nancy Moureau, PhD, RN, CRNI®, CPUI, VA-BC, is a globally recognized leader and the founder of PICC Excellence, Inc., a premier provider of education on infusion therapy and vascular access device (VAD) insertion and care for over 3 years. Dr Moureau’s extensive clinical experience includes pediatric, neonatal, intensive care unit (ICU) peripherally inserted central catheter (PICC)/IV teams, and home infusion care.

    As CEO of PICC Excellence, she leads the development of over 8 online educational courses and pathways, emphasizing insertion competency and evidence-based practices. Her responsibilities include education development, research, global speaking engagements, legal reviews, manufacturer consulting, and active clinical practice for peripheral and central vascular access.

    Dr Moureau pioneered PICC Certification™ (CPUI™) and Neonatal PICC Credentialing (CNPI) programs, validating inserters' education and competency. Most recently, she introduced a systematic UGPIV Mastery Learning Process, an ultrasound-guided peripheral insertion toolbox that earned the Infusion Nurses Society’s (INS) Seal of Approval—the first of its kind.

    To connect with Dr Moureau, visit www.piccexcellence.com, or email her at nancy@piccexcellence.com.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: October 16, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Extravasation Treatment: A Case Study Approach to Explore Options
    Contains 3 Component(s), Includes Credits Recorded On: 09/18/2024

    The treatment of an extravasation, the inadvertent delivery of a vesicant into the tissue around a vascular access device (VAD), is a source of patient harm that is under-recognized, under-reported, and thus likely ineffectively treated. Unfortunately, recommendations for extravasation treatment (primarily reliant on case reports) can be difficult to leverage into clear clinical guidelines, increasing the risk of inadequate or delayed post-extravasation monitoring and treatment. This presentation will review vesicant properties and their mechanisms of tissue injury, peripheral vs central VAD extravasation risks with related prevention measures, and recommended extravasation treatment strategies and resources using a case study approach.

    The treatment of an extravasation, the inadvertent delivery of a vesicant into the tissue around a vascular access device (VAD), is a source of patient harm that is under-recognized, under-reported, and thus likely ineffectively treated. Unfortunately, recommendations for extravasation treatment (primarily reliant on case reports) can be difficult to leverage into clear clinical guidelines, increasing the risk of inadequate or delayed post-extravasation monitoring and treatment. This presentation will review vesicant properties and their mechanisms of tissue injury, peripheral vs central VAD extravasation risks with related prevention measures, and recommended extravasation treatment strategies and resources using a case study approach.

    Objectives:

    • Describe the properties of the major vesicant categories that may precipitate tissue injury
    • Relate the relative extravasation risks of peripheral vs central VADS to extravasation prevention strategies
    • Describe current recommendations for treatment of selected vesicant extravasations, using a case study approach

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a health care center in Nebraska. She is responsible for staff development, competency assessment, and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel was a co-author of the 2021 Infusion Nurses Society Infusion Therapy Standards of Practice, was Chair of the 2024 9th edition of the INS Standards of Practice Committee and is chair of the 2027 INS Standards Committee. She has authored several publications and speaks nationally on optimization of infusion therapy outcomes. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 18, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Oncology Infusion Therapy in Home and Ambulatory Sites of Service
    Contains 3 Component(s), Includes Credits Recorded On: 08/21/2024

    The need for alternate sites of care for oncology patients is growing with the expansion of the biologic drug portfolio. Insurance companies are shifting patients from hospital sites of service to independent providers, and the home and ambulatory clinic settings are now an attractive option for patients seeking more convenient sites for their infusions. In this session, we will outline the framework necessary to design an oncology infusion program, the policies and procedures necessary, and components of training needed to meet the challenges that serving this population of patients brings.

    The need for alternate sites of care for oncology patients is growing with the expansion of the biologic drug portfolio. Insurance companies are shifting patients from hospital sites of service to independent providers, and the home and ambulatory clinic settings are now an attractive option for patients seeking more convenient sites for their infusions. In this session, we will outline the framework necessary to design an oncology infusion program, the policies and procedures necessary, and components of training needed to meet the challenges that serving this population of patients brings.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • list the critical components necessary to provide safe infusion care for the oncology population
    • discuss the process used to determine medications’ appropriateness in the alternate infusion setting
    • describe key points for a training program to be used for nurses in the expansion of their skillset to include oncology
    • define effective communication methods and patterns to support the administration of oncology therapies in a setting outside of hospital outpatient facilities or physician office. 

    Pamela Jones McIntyre, MSN, RN, CRNI®, IgCN, OCN, VA-BC

    Pamela Jones McIntyre, MSN, RN, CRNI®, IgCN, OCN, VA-BC, has over 4 decades of comprehensive nursing experience. She is considered a subject matter expert in infusion therapy, with extensive experience operating ambulatory infusion clinics for specialty and oncology therapies, and 24 years of experience as an operator and Vice President of Clinical Services for home infusion. Recent projects have focused on expanding oncology biologic therapies to alternate sites of infusion, which Ms. McIntyre is determined to see accomplished safely and in the best interest of the patients and providers. She provides consulting services to health care organizations for infusion nursing program development and newly established ambulatory infusion centers through her LLC, Expert Infusion Nurse Consulting.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: August 21, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Implanted Vascular Access Devices: Back to the Basics in Care and Management
    Contains 3 Component(s), Includes Credits Recorded On: 06/11/2024

    Over 2 billion intravascular devices are inserted globally each year, and determining optimal maintenance protocols is challenging. Literature cites late complications of central venous access devices (CVAD) range from 7.2% to 32.1%. Implanted vascular access devices (IVADs) are quoted to have lower risk than other CVADs but are not risk-free. Despite risk, patients often retain their devices for extended periods. In this session, we will review the basics of care and management of IVADs and let evidence-based practice guide the way to minimizing potential complications.

    Over 2 billion intravascular devices are inserted globally each year, and determining optimal maintenance protocols is challenging. Literature cites late complications of central venous access devices (CVAD) range from 7.2% to 32.1%. Implanted vascular access devices (IVADs) are quoted to have lower risk than other CVADs but are not risk-free. Despite risk, patients often retain their devices for extended periods. In this session, we will review the basics of care and management of IVADs and let evidence-based practice guide the way to minimizing potential complications.  

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    • Identify best practices when accessing IVADs, including pre-assessment, skin preparation, needle access, and positioning. 
    • Discuss dressing changes and options available when patients have skin variables making dry and intact dressings difficult to achieve. 
    • Review how tubing changes vary dependent on the infusate.
    • Compare variances in flushing frequency and options related locking solutions.

    Mary Jo Sarver, MN, ARNP, AOCN, CRNI®, VA-BC, LNC

    CEO

    Sarver Better Living

    Mary Jo Sarver, MN, ARNP, AOCN, CRNI®, VA-BC, LNC, has more than 37 years of experience in infusion therapy and oncology/hematology care. Her role focuses on continuity of care and seamless transitions for patients within and outside the acute care setting. She collaborates and acts as a consultant locally and on a system level for Providence, guiding staff development, competency assessment, and process improvement to improve outcomes in multiple areas of clinical practice and new graduate transition to practice. She attends cancer care conferences, rounds in the clinics and hospital, and actively consults and sees patients and families for treatment and care planning. She has published, conducted research, and spoken on multiple topics within the United States. For decades, passion has prompted her to participate both locally on the Puget Sound Infusion Nurses Society (PSINS), Puget Sound Oncology Nursing Society (PSONS), and American Cancer Society (ACS) boards and to nationally assume various roles through the Infusion Nurses Society (INS) and Oncology Nursing Society) (ONS). She is CEO of Sarver Better Living Products LLC, a family-run company.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: June 11, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.